Frederiksstaden Pharma ApS
CVR number: 25630483
Frederiksgade 11, 1265 København K
tel: 36495500
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 225.12 | 2 043.72 | - 666.38 | 13.10 | -79.85 |
| Employee benefit expenses | -3 115.30 | -3 303.97 | -1 351.63 | ||
| Total depreciation | -40.70 | -60.29 | -37.39 | ||
| EBIT | -1 930.89 | -1 320.54 | -2 457.94 | 13.10 | -79.85 |
| Other financial income | 0.01 | ||||
| Other financial expenses | -13.98 | -18.92 | 9.72 | -9.34 | -3.86 |
| Net income from associates (fin.) | - 786.63 | 431.63 | |||
| Pre-tax profit | -1 944.86 | -2 144.45 | -2 022.00 | 3.76 | -82.30 |
| Income taxes | 371.43 | 611.60 | |||
| Net earnings | -1 944.86 | -1 773.02 | -1 410.40 | 3.76 | -82.30 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 295.27 | ||||
| Intangible assets total | 295.27 | ||||
| Buildings | 138.75 | 96.86 | |||
| Machinery and equipment | 23.00 | 26.50 | |||
| Tangible assets total | 161.75 | 123.36 | |||
| Holdings in group member companies | 1 013.37 | ||||
| Other receivables | 235.92 | 241.82 | |||
| Investments total | 235.92 | 1 255.19 | |||
| Long term receivables total | |||||
| Raw materials and consumables | 469.08 | 523.65 | |||
| Inventories total | 469.08 | 523.65 | |||
| Current trade debtors | 727.93 | 2 308.88 | 125.00 | ||
| Current other receivables | 4 353.65 | 733.74 | 125.25 | 138.82 | 33.22 |
| Current deferred tax assets | 371.43 | 611.60 | |||
| Short term receivables total | 5 081.58 | 3 414.05 | 736.85 | 263.82 | 33.22 |
| Balance sheet total (assets) | 5 948.33 | 5 316.25 | 736.85 | 263.82 | 328.49 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 158.70 | 158.70 | 158.70 | 158.70 | 158.70 |
| Other reserves | 230.31 | ||||
| Retained earnings | 5 196.81 | 3 251.94 | 1 478.92 | 68.52 | - 158.03 |
| Profit of the financial year | -1 944.86 | -1 773.02 | -1 410.40 | 3.76 | -82.30 |
| Shareholders equity total | 3 410.64 | 1 637.62 | 227.22 | 230.98 | 148.69 |
| Non-current accruals and deferred income | 534.29 | 345.72 | |||
| Non-current other liabilities | 981.25 | ||||
| Non-current liabilities total | 534.29 | 1 326.97 | |||
| Current loans from credit institutions | 450.00 | ||||
| Other non-interest bearing current liabilities | 1 814.82 | 1 713.09 | 509.63 | 32.84 | 179.80 |
| Accruals and deferred income | 188.57 | 188.57 | |||
| Current liabilities total | 2 003.39 | 2 351.66 | 509.63 | 32.84 | 179.80 |
| Balance sheet total (liabilities) | 5 948.33 | 5 316.25 | 736.85 | 263.82 | 328.49 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.